戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 he physiological insulin balance between the hepatic portal and peripheral circulations and thereby a
2 ted from the femoral artery and vein and the hepatic, portal, and renal veins to determine total hemo
3  mediated by vagal afferents innervating the hepatic portal area (HPA), through which most water and
4  The arterial glucagon levels (ng/l) and the hepatic portal-arterial difference in plasma glucagon (n
5   The arterial glucagon level (ng/l) and the hepatic portal-arterial difference in plasma glucagon (n
6       Arterial glucagon level (ng/l) and the hepatic portal-arterial difference in plasma glucagon (n
7  The arterial plasma glucagon levels and the hepatic portal-arterial difference in plasma glucagon de
8         The arterial glucagon levels and the hepatic portal-arterial difference in plasma glucagon in
9 erial plasma insulin levels (pmol/l) and the hepatic portal-arterial difference in plasma insulin (pm
10       Arterial plasma insulin levels and the hepatic portal-arterial difference in plasma insulin dec
11   The arterial plasma insulin levels and the hepatic portal-arterial difference in plasma insulin inc
12                                          The hepatic portal-arterial difference in plasma insulin was
13                                          The hepatic portal-arterial difference in plasma insulin was
14 ned, the insulin and glucagon levels and the hepatic portal-arterial difference remained constant.
15      The insulin and glucagon levels and the hepatic portal-arterial differences remained constant.
16                                              Hepatic portal ascorbate accumulation was nearly abolish
17 ive agent of schistosomiasis, resides in the hepatic portal circulation of their human host up to 30
18 n distribution in arterial, deep venous, and hepatic portal circulation.
19 anced fructose uptake and transport into the hepatic portal circulation.
20              The biliary ductual ectasia and hepatic portal fibrosis associated with ARPKD have not b
21 ar hyperplasia along with varying degrees of hepatic portal fibrosis that is indistinguishable from t
22 primarily palliative, whereas MLPVB restores hepatic portal flow in patients with EHPVT.
23 that a commitment to life in the endothermic hepatic portal system favored a filiform body form for e
24  choice for the identification of gas in the hepatic portal system in children.
25                                  Because the hepatic portal system may not be the optimal site for is
26 ective activation of the nerve plexus of the hepatic portal system via peripheral focused ultrasound
27 and IL21R in PBC livers (particularly in the hepatic portal tracks) support a disease mechanism in wh
28 memory B and plasma cells accumulated in the hepatic portal tracts of PBC patients.
29 e alveolar edema in the absence of necrosis, hepatic-portal triaditis, mononuclear-cellular infiltrat
30 ve islet transplant (n = 400 islets) via the hepatic portal vein (HPV) with fibroblast growth factor
31                 Levels of amino acids in the hepatic portal vein and caudal vein were measured at int
32 lycogen synthesis during hyperinsulinemia or hepatic portal vein glucose infusion in vivo.
33          Specifically, it is unlikely that a hepatic portal vein glucose sensor signaling RYGB-induce
34 ch potentially sensing glucose levels in the hepatic portal vein has recently been suggested in a mou
35 n for essential amino acids over time in the hepatic portal vein in contrast to that of the non-selec
36 luate an alternate method of administration, hepatic portal vein infusion of G207 was performed in a
37                    Using a pancreatic clamp, hepatic portal vein insulin delivery was increased three
38 oon HGU and glycogen storage, unlike morning hepatic portal vein insulin delivery, which did.
39                                          The hepatic portal vein is the main vascular route responsib
40 V-AGA) was constructed and injected into the hepatic portal vein of Fabry mice.
41 ic acid, 80 +/- 12% of labeled folate in the hepatic portal vein was unmodified folic acid.
42     Hepatocytes are usually infused into the hepatic portal vein with many cells rapidly cleared by t
43 dy compared insulin infusion via endogenous (hepatic portal vein) and clinical (peripheral) routes to
44 ntegrity of vagal nerve supply to the liver, hepatic portal vein, and the proximal duodenum provided
45 ecretory bursts at ~5-min intervals into the hepatic portal vein, these pulses being attenuated early
46 s transfer to host epithelial tissue and the hepatic portal vein.
47 n the cecum and in plasma collected from the hepatic portal vein.
48                Eight dogs underwent combined hepatic/portal vein catheterization and infusion of D4-c
49 7%, ascites was present in 84%, and abnormal hepatic portal venous flow was present in 35%.
50                                              Hepatic portal venous gas (HPVG) is a rare imaging findi
51                                              Hepatic portal venous gas (HPVG) is an ominous radiologi
52 nts underwent transjugular liver biopsy with hepatic portal venous gradient (HPVG) measurements.